STRATEGIC CLINICAL INNOVATION ORGANIZATION (SCIO)
Live / Registered — Registered (as of 07 Nov 2023)
What this means for you
Registered since 07 Nov 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97163869
- Registration number
- 7210095
- Mark type
- Stylized text
- Filed
- 09 Dec 2021
- Published for opposition
- 22 Aug 2023
- Registered
- 07 Nov 2023
- Attorney of record
- Michelle Rosenberg
Goods and services
- Class 035 — Advertising and business services: Business consulting and management in the field of medical and scientific research and development and clinical trials for biotechnology, pharmaceutical, and medical device companies, namely, assisting companies with developing business strategies and road maps for medical and scientific research and development; assisting companies in the nature of business advisory services in the field of business plan development for biotechnology, pharmaceutical, and medical device companies; assisting companies with trial feasibility in the nature of providing independent review of clinical trials for business purposes; assisting companies with clinical trials compliance, in the nature of business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials, and applications for drug approval; business concept development and implementation in the field of the pharmaceutical industry; business consulting and management in the field of clinical trials, namely, providing information management services; business management and development consulting services for clinical research organizations (CRO), drug manufacturers, and providing in-house and out-sourced business functions and activities, namely, outsourcing services and office administration services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of biopharmaceutical companies to assist them with clinical research, clinical trials, and applications for drug approval in the fields of genetics, epigenetic, biologics and small molecule therapeutics, drugs, combination drug and device products; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; and assisting companies with developing global regulatory approval strategies and navigating the regulatory submission and approval process, all in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of clinical trials; consulting services for others in the field of design, planning, and implementation project management of clinical trials
Owner
- Boston Biotech Clinical Research, LLC, Natick, MA, US
- Boston Biotech Clinical Research, LLC, Natick, MA, US
- Boston Biotech Clinical Research, LLC, Natick, MA, US
Prosecution history
- 07 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 22 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Aug 2023 — PUBLISHED FOR OPPOSITION
- 02 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Jul 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jul 2023 — EXAMINER'S AMENDMENT ENTERED
- 18 Jul 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 18 Jul 2023 — EXAMINERS AMENDMENT E-MAILED
- 18 Jul 2023 — EXAMINERS AMENDMENT -WRITTEN
- 03 May 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 03 May 2023 — FINAL REFUSAL E-MAILED
- 03 May 2023 — FINAL REFUSAL WRITTEN
- 15 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE